Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
2023 · Nature Medicine · 163 citations
https://doi.org/10.1038/s41591-023-02476-4
D
David Aguillón
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
147
Papers
1.9K
Citations
22
h-index
30
i10-index
David Aguillón is an academic researcher from Universidad de Antioquia. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Alzheimer's disease research and treatments & Genomics and Rare Diseases. The author has an h-index of 22, co-authored 125 publications.
ORCID: 0000-0003-2283-536XPapers by this author
works<i>APOE3</i> Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease
2024 · New England Journal of Medicine · 47 citations
https://doi.org/10.1056/nejmoa2308583
Protective genetic variants against Alzheimer's disease
2025 · The Lancet Neurology · 9 citations
https://doi.org/10.1016/s1474-4422(25)00116-4
Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease
2025 · Alzheimer s Research & Therapy · 7 citations
https://doi.org/10.1186/s13195-025-01711-z
Connectome‐based predictive modeling of brain pathology and cognition in autosomal dominant Alzheimer's disease
2025 · Alzheimer s & Dementia · 5 citations
https://doi.org/10.1002/alz.70061
Nutritional Assessment in Patients with Early-Onset Autosomal Dominant Alzheimer's Disease Due to PSEN1- E280A Genetic Variant: A Cross-Sectional Study
2021 · Journal of Aging Research and Lifestyle · 1 citations
https://doi.org/10.14283/jarlife.2021.6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat